ICYMI: US Scientists Break Ground by Modifying Human Embryos for the First Time
Source: Pixabay

ICYMI: US Scientists Break Ground by Modifying Human Embryos for the First Time

Your hear that? It's the sound of the future knocking on the door! The MIT Technology Review reports about the first-known experiment to edit human embryos in the United States using a…

Continue Reading ICYMI: US Scientists Break Ground by Modifying Human Embryos for the First Time

Editor’s Choice: Survivor Status and Orphan Status are Both Good Signs in the Rare Disease World

Happy Friday! This week, we have a story that might break your heart about a woman who battled cystic fibrosis. But we also have a story that might inspire you about a…

Continue Reading Editor’s Choice: Survivor Status and Orphan Status are Both Good Signs in the Rare Disease World
New Study of Trigeminal Neuralgia (TN) Often Preceding a MS Diagnosis
[Source: pixabay.com]

New Study of Trigeminal Neuralgia (TN) Often Preceding a MS Diagnosis

Trigeminal neuralgia (TN), or extreme, sudden facial pain associated with the 5th cranial nerve, occurs frequently in patients who have received a multiple sclerosis (MS) diagnosis. In a survey with 8,590 respondents,…

Continue Reading New Study of Trigeminal Neuralgia (TN) Often Preceding a MS Diagnosis
Targeting the Mutation, Not the Disease is Bringing Treatment to the Ultra-Rare Community
Source: pixabay.com

Targeting the Mutation, Not the Disease is Bringing Treatment to the Ultra-Rare Community

The U.S. FDA just announced that it has accepted Genentech’s supplemental New Drug Application (sNDA) and has granted Priority Review for Zelboraf (vemurafenib) in patients with Erdheim-Chester disease from the…

Continue Reading Targeting the Mutation, Not the Disease is Bringing Treatment to the Ultra-Rare Community